Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of both genders with age group between 15-85 years 2. Subjects with Musculo-skeletal pain due to idiopathic, systemic or trauma for more than 24 hours. 3. Pain of VAS scale between 5-44mm (Mild pain) to 45-74 mm (Moderate pain) 4. Subjects who are willing to give written consent.
Exclusion criteria
Exclusion criteria: 1.Subjects suffering from co-morbidities like rheumatoid arthritis, gouty arthritis or psoriatic arthritis. 2.Participants with the history of fracture of the joint. 3.Subjects under cortico-steroids, NSAIDS or systemic analgesics. 4.Subjects with gross disability having difficulty performing their routine chores. 5.Hypersensitive to any of the ingredients of the product. 6.Open wounds or injury at the site of application of oil. 7.Any other condition which the investigator feels will jeopardize the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Change in pain intensity measured through Visual Analogue Scale (VAS) scale from baseline to 15 days. 2.Change in functional ability measured through Brief Pain Inventory questionnaire (BPI) from baseline to 15 days. 3.Average time taken for reducing the pain and duration of effectiveness of the oil. Timepoint: Day 0, Day 8 and Day 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in swelling, tenderness or stiffness as per gradation (if present) 2. Change in PEG (Pain, enjoyment, general activity) tool from baseline to 15 days 3. Improvement in sleep from baseline to 15 days 4. Any changes in pigmentation if present 5. Local adverse events (redness, itching, burning)/ tolerability of the product 6. Serious adverse events Timepoint: Day 0 and Day 15 | — |
Countries
India
Contacts
Greenspace